p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 15.0px Calibri} Mary is the scientific consultant of a firm of investors interested in biotechnology. She is asked to evaluate the research plan of a small...

Mary is the scientific consultant of a firm of investors interested in biotechnology. She is asked to evaluate the research plan of a small company producing engineered variants of the protease subtilisin from
Bacillus subtilis
used in detergents. The company plans to use
Escherichia coli
as the host for the expression of these variants. The investors Mary is representing ask her to prepare a report evaluating the feasibility of this approach.